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Mouse monoclonal antibodies (MAbs) specific for the lipopolysaccharide (LPS) core types R1,
R2, and R3 of Escherichia coliand a cross-reactive MAb that binds to the LPS core of almost all
E. coli were used in ELISA to determine the frequency of cores resembling R1, R2, and R3 in
strains of E. coli isolated from clinical samples (blood and urine specimens) and from the feces of
asymptomatic individuals. Of the 180 wild-type isolates, 123 were assigned to R1 core type, 14 to
R2, and 18 to R3. Twenty-five wild-type E. coliisolates could not be assigned to a particular core
type and may have either an R4 or K12 core or a previously unrecognized core type. R1 core type
was associated with 0 types 1,4,6,8, and 18 and with K1 or K5 capsules. R3 was associated with
015. 075 isolates could be of either R1 or R2 core type.
The lipopolysaccharide (LPS) core region of Escherichia
coli has a conserved overall structure, with an inner 2-keto-3-
deoxy-octonate-heptose region and an outer hexose region.
Most of the variation that does occur is in the outer part of
the core, furthest from lipid A. In wild-type smooth E. coli.
the core region can occur in at least four different forms,
known as R 1, R2, R3, and R4 [1-3]. The naturally rough
strain Kl2 has a different core region [4].
The 0 antigen of smooth LPS may mask some of the epi-
topes and phage attachment sites in the core region. The
chemical, serologic, and phage typing methods that have
been used to define the different core types of E. coli are
therefore not directly applicable to wild-type smooth strains.
The frequency with which these different core types occur in
wild-type E. coli is therefore not known.
Little is known about the association between core types
and 0 serotypes ofE. coli. except that the original R 1and R2
rough mutants were both derived from 08 strains [I] and
that the original R3 mutant was derived from an 0 III strain
[2]. There is no published evidence on the relationship of
LPS core types to capsular types or to virulence. Information
about the distribution of0 and K antigens has proved to be
useful, for example in identifying and understanding entero-
pathogenic strains [5] and in suggesting novel therapeutic
approaches to bacteremia [6]. Information about core types
might be equally interesting.
We therefore set out to produce a panel ofmouse monoclo-
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nal antibodies (MAbs) that would react with specific LPS
core types of E. coli and other gram-negative bacilli with
related core structures. We wished to use these MAbs as a
means of determining the LPS core types of a collection of
wild-type E. coli.
Materials and Methods
Bacteria and bacteriophages. E. coli RI (F470), R2 (F576),
R3 (F653), R4 (2513) and KI2 (2131) and rough-specific
phages FO, BrIO, C21, 6SR, and T4 were obtained from G.
Schmidt (Forschunginstitut, Borstel, Germany). E. coli 0 I, 02,
04, 06, 012, 015, 018, and 075 were obtained from A. S.
Cross (Walter Reed Army Institute, Washington, DC). Phages
specific for E. coli capsular types KI (<f>KIGS) and K5
(<f>K5DG) were obtained from A. P. Roberts (Charing Crossand
Westminster Medical School, London). Blood culture and urine
isolates were obtained from the Clinical Bacteriology Labora-
tory, Department of Medical Microbiology, Edinburgh Univer-
sity, from routine clinical specimens. The blood culture isolates
were all of the gram-negative organisms isolated in a l-year pe-
riod. Twenty-one fecal isolates of E. coli were obtained, each
from a separate healthy volunteer. Rough mutants of Salmo-
nella minnesota (R60), Salmonella typhimurium (1542), Kleb-
siella pneumoniae (M lOB), and Pseudomonas aeruginosa
(PAC608) and wild-type smooth Shigella sonnei (colicin types
4/2 and 2/ I) and Shigella flexneri (serotypes 1a and 3) were
freeze-dried stock cultures held in our laboratory.
MAbs. MAbs were produced by standard methods [7]. The
details of immunization schedules and selection procedures are
to be published elsewhere. All were reactive in ELISAwith poly-
myxin-complexed rough LPS [8]. All MAb preparations were
supernatants of hybridoma cell cultures grown in RPMI 1640
supplemented with 5% fetal calf serum. Antibody concentration
was in the range of 10-50 Jl-g/mL.
ELISA. Overnight nutrient broth cultures of bacteria were
washed and resuspended in saline to give an OD of 0.5 at 525
nm and heated for 30 min at 100ce. Cells were then diluted
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1/20 in coating buffer (sodium carbonate-bicarbonate, pH 9.6,
with 0.05% sodium azide) and 100 JLL/well was added to Nunc
(Roskilde, Denmark) Polysorb strips. After overnight incuba-
tion at room temperature, plates were washed three times with
wash buffer (0.05% Tween 20 and 0.05% sodium azide in PBS,
pH 7.4) and postcoated with 5%(wt/vol) bovine serum albumin
(BSA) in coating buffer overnight at room temperature. Plates
were then washed and stored at - 20°e.
MAbs were diluted 1/250 in dilution buffer (4%[wt/vol] poly-
ethylene glycol, 0.05% sodium azide, and 0.05% tween 20 in
PBS, pH 7.4). Diluted MAb (100 JLL) was added to wells and
incubated for 90 min at 37°e. Plates were washed three times,
and urease-conjugated anti-mouse immunoglobulin (Zymed,
Cambridge, UK; diluted 1/500 in dilution buffer with 0.5%
BSA, 100 JLL/well) was added and incubated for a further 90
min. Plates were then washed three times in wash buffer and
three times in distilled water; urease substrate solution (Seralab,
Crawley Down, UK; 100 JLL/well) was added and plates were
incubated for 90 min at room temperature and read at 590 nm.
An OD of >0.8 was considered positive.
PAGE and immunoblotting. LPS was prepared by proteinase
K (protease type XI; Sigma, Poole, UK) digestion oflysed bacte-
ria [9] and separated on 14%polyacrylamide gels [ I0] with SDS
omitted from stacking and separating buffers. Gels were then
silver stained [9] or blotted to nitrocellulose membrane (0.2-JLm
pore size) [II]. Blots were blocked with 3%(wt/vol) gelatin in
TRIS-buffered saline, pH 7.5 (TBS), incubated for 3 h in a 1/10
dilution ofMAb in I%gelatin in TBS followed by a l-h incuba-
tion with horseradish peroxidase anti-mouse IgO conjugate
(lCN, High Wycombe, UK; diluted 1/1000), and developed
with horseradish peroxidase color reagent (Bio-Rad, Hemel
Hempstead, UK).
Serum sensitivity of bacteria. Serum from one donor was
stored at -70°e. This serum had IgO antibodies to LPS core at a
level equal to the 65th centile of the normal population [8].
Overnight broth cultures were washed and resuspended in com-
plement fixation test (CFT) buffer (Oxoid, Basingstoke, UK) at
room temperature to an OD of 0.5 at 525 nm. This suspension
was then diluted 1/5000 in CFT buffer, and 10 JLL was added to
70 JLL of CFT buffer and 20 JLL of freshly thawed serum or
heated (56°C, 30 min) serum. After I h at 37°C, duplicate 20-
JLL samples were spread on the surface of nutrient agar plates,
and colonies were counted after overnight incubation. If the
number ofcolony-forming units in the fresh seru,mwas < 10%of
the number in the heated serum, the organism was considered to
be serum sensitive.
o typing. E. coli isolates from blood and urine cultures were
screened for common 0 antigens, by ELISA with absorbed 0
typing sera (Difco, Detroit) to 01, 02, 04, 06,07,012,015,
018, 022, and 075 (diluted 1/ I000) and by tube agglutination
at a final dilution of 1/80 with unabsorbed sera to 08 and 09
(Statens Seruminstitut, Copenhagen). 0 types were confirmed
by conventional tube agglutination [12].
Phage typing. Nutrient agar plates were surface inoculated
by flooding with overnight broth culture and allowed to dry.
Phage suspension (10 JLL) was dropped onto the agar and incu-
bated overnight. A clear zone of lysis was scored as sensitive.
Table 1. Reactivity of selected monoclonal antibodies (M~bs) in
ELISA.
Reactivity with E. coli strain
MAb RI R2 R3 R4 KI2 012 015 018
SZ 433.4.8 + +
H4361.23 + +
W4434.07 + +
SZ 27 150.3 + + + + + + + +
NOTE. +, strong reactivity (00 >0.8); -, no or weak reactivity (00
<0.15).
Statistics. All P values are two-tailed results calculated by
Fisher's exact test.
Results
Selection of core-specific MAbs. A preselected panel of
LPS-reactive MAbs was tested by ELISA against heat-killed
E. coli rough strains RI, R2, R3, R4, and K12; E. .coli
smooth strains 01, 02, 04, 06, 012, 015, 018, and075;
and the rough mutants of K. pneumoniae, P. aeruginosa, S.
minnesota, and S. typhimurium. MAbs that reacted with a
restricted range ofR types and also with some smooth strains
of E. coli were thought likely to be useful in core typing
wild-type smooth strains. Four such distinct patterns of reac-
tivity were observed with more than one antibody. R I-spe-
cific MAbs (e.g., SZ 43 3.4.8) reacted with RI and with E.
coli 01,02,04,06,018, and 075; R2-specific MAbs (e.g.,
H4 361.23) reacted with R2 and 012; R3-specific MAbs
(e.g., W4 434.07) reacted with R3 and 015; cross-reactive
MAb SZ 27 150.3 reacted with all the E. coli rough and
smooth strains and with the Salmonella rough mutants but
not with the Klebsiella or Pseudomonas rough mutants
(table I).
Other patterns were observed, including a group ofMAbs
that reacted with R2 and K 12, with R2 and the Salmonella
rough mutants, or with all of these strains. However, no
MAb reacted with KI2 or R4 but not with other rough mu-
tants. None of the MAbs used in this study reacted with the
Klebsiella or Pseudomonas rough mutants tested.
The specificity of MAbs for LPS core was confirmed, for
the MAbs given as examples above, by immunoblotting
against LPS (proteinase K extracts) from E. coli R I, R2, R3,
R4, K12, 012, 015, and 018. The 012, 015, and 018
strains were chosen as they seemed, from the ELISA data, to
represent smooth strains with R2, R3, and R I core types,
respectively. As seen in figure I, the immunoblots showed
reactivity ofeach MAb with a band corresponding to the LPS
core ofeach ofthe organisms with which it reacted in ELISA.
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Figure 1. Proteinase K prepara-
tions of LPS from E. coli. Lanes 1-8:
Strains RI, R2. R3. R4. K12 , 012,
015, and 018. A: Silver stain; B-D,
respectively: Immunoblots obtained
with SZ 43 3.4.8 (RI-specific), H4
361.23 (R2 specific). W4 434 .07
(R3 specific), and SZ 27 150.3
(cross-reactive).
With the rough mutants, a band was seen that corresponded
to the single band seen in the silver stain. With the smooth
strains. the RI and R3 MAbs again reacted with a single
band corresponding to the fastest-moving band seen in the
silver stain. This band consists ofLPS core that has not been
substituted with 0 antigen [13]. The R I antibody reacted in
the same way in blots with the 0 I, 02, 04, 06, and 075
strains (not shown). The R2-specific MAb H4 361.23 and
the cross-reactive MAb SZ 27 150.3 reacted with the unsub-
stituted core band and also with the "ladder" pattern of
bands corresponding to O-substituted LPS core. MAb SZ 27
150.3 reacted weakly in the blot with bands in the R I and
R4 LPS preparations that were not visible in the silver stain .
We believe these bands represent production, due to a leaky
mutation. of small quantities of O-substituted LPS that are
not detected by the silver stain but are detected by immuno-
blot.
Binding of anti-LPS core MAbs to gram-negative bacilli
other than E. coli. Four Shigella strains were tested in
ELISA, and all reacted with the cross-reactive MAb. In addi-
tion, both S. sonnei strains reacted with the R I-specific MAb,
while the S. ftexneri strains reacted with the R3-specific
MAb. This is in agreement with previous studies ofLPS core
in these species [14-16]. Blood culture isolates of other
gram-negative genera (Acinetobacter, 7; Citrobacter, 5; En-
terobacter, 18; Klebsiella, 14; Proteus, 9; Providencia, I; Pseu-
domonas, 8; Salmonella, 2; and Serratia, 5) were also tested
in ELISA with the core type-specific and cross-reactive
MAbs. The only positive reaction observed was between the
two Salmonella isolates and the cross-reactive MAb. The
cross-reactive MAb SZ 27 150.3 was tested in an immuno-
blot against LPS (proteinase K extracts) from single blood
culture isolates of K. pneumoniae, Proteus mirabilis, P. aeru-
ginosa. Enterobacter cloacae. and Citrobacter freundii. No re-
action was observed with any of these isolates, confirming
the lack of reactivity seen in ELISA.
Frequency ofMAb-defined core types in wild-type isolates of
E. coli. E. coli isolates from blood cultures (n = 79). urine
cultures (n = 80). and fecal specimens from asymptomatic
volunteers (n = 21) were tested in ELISA with core type-
specific and cross-reactive MAbs. The cross-reactive MAb
reacted with all of the isolates tested except for two of the
urine isolates. When the strains reacting with the cross-reac-
tive MAb were tested with the R 1-, R2-. and R3-specific
MAbs. each MAb reacted with a mutually exclusive group of
isolates, which were classified as R 1. R2. and R3, respec-
tively. Figure 2 illustrates these results for the fecal isolates.
Of the two urine isolates that did not react with the cross-
reactive antibody, one reacted with the R I antibody. These
and the isolates that did not react with any of the core-speci-
fic antibodies are referred to as RNC (not classified). The
numbers ofwild-type isolates in the four categories are given
in table 2. R I was the most common classification overall
(123/181, 68%) and was more common among isolates from
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Figure 2. Reactivity (ELISA optical den-
sity) of antibodies with 21 fecal E. coli show-
ing mutually exclusive reactions. Shading in-
dicates core type to which each strain was
assigned.
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urine (62/80, 78%) than among those from blood culture
(48/79, 61%, P = .017) or feces (11/21, 52%, P = .030).
Those MAbs that had reacted with R2, K 12, and Salmo-
nel/a rough mutants reacted with all of the R2 group ofwild-
type isolates but also reacted with variable numbers of the
RNC isolates. This showed that the RNC group was heteroge-
neous but did not permit clear subdivision of this group.
Relationship between MAb-defined core type and sensitivity
to rough-specific and K-specific phages (table 3). The collec-
tion of wild-type E. coli was tested for sensitivity to the
rough-specific phages that have been used to distinguish be-
tween the different R types ofE. coli [3], since it was thought
that the pattern of reactivity might support the MAb-defined
R typing scheme. Fifty of the 180 isolates tested were sensi-
tive to one or more of the rough-specific phages. They were
found among each of the R types defined with MAbs. They
included isolates that were 0 typeable and produced a ladder
Table 2. Frequency of core types in wild-type isolates of E. coli
determined by binding of core-type-specific monoclonal antibod-
ies (MAbs) in ELISA.
No. (%) of strains assigned to MAb-defined
core type
Source RI R2 R3 RNC Total
Blood culture 48 (61) 6 (7) 12 (15) 13 (16) 79
Urine 64 (81) 4 (5) 4 (5) 8 (10) 80
Feces II (52) 4 (19) 2 (10) 4 (19) 21
Total 123 (68) 14 (8) 18 (10) 25(14) 180
NOTE. NC not classified.
Table 3. Sensitivity of 180 E. coliofdifferent core types to rough-
specific, K l-specific, and K5-specific phages.
No. of strains sensitive to phage
Core type
(n) FO BrIO C21 6SR T4 AnyR+ KI K5
RI (123) 0 8 17 5 28 40 19 20
R2 (14) 0 2 0 I 3 3 0 I
R3 (18) 0 0 0 0 2 2 0 I
RNC (25) 0 3 2 2 3 5 3 2
Total (180) 0 13 19 8 36 50 22 24
NOTE. Any R+, any rough-specific phage; NC not classified.
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Table 4. o type of E. coliof different core types from blood and
urine cultures.
No. of each core type associated with 0 type
Core type
(n) 01 02 04 05 06 07 08 015 018 075 NT
RI (112) II 0 6 I 26 3 3 0 10 6 46
R2 (10) 0 0 0 0 0 0 0 0 0 3 7
R3 (16) 0 0 0 0 0 0 0 3 0 0 13
RNC (21) I 2 0 0 0 2 0 0 0 0 16
Total (159) 12 2 6 I 26 5 3 3 10 9 82
NOTE. NT. not typed by available O-specific sera; NC, not classified.
pattern on silver stain of LPS, as was found by Cross et al.
[6]. C21 sensitivity, a marker for the R 1 rough mutant, was
found in 19 isolates (17 R 1 and 2 RNC). FO sensitivity is a
marker for R2 rough mutants, but no isolate was FO sensi-
tive. There was no other discernible relationship between R
type and sensitivity to particular rough-specific phages.
Forty-six of the 180 isolates were sensitive to one of the
two K-specific phages. The R 1 isolates accounted for 19 of
the 22 K1 isolates and 20 of the 24 K5 isolates found.
Relationship between MAb-defined core type and 0 type
among the urine and blood culture isolates. The urine and
blood culture isolates of E. coli were tested for 12 0 types
found commonly among E. coli from blood culture [6, 12] or
urinary tract infection [17] (table 4). The overall proportion
of isolates that belonged to one of these 0 types was much
higher among those of Rl core type (66/112, 58%) than
among the other core types (11/47, 23%, P = .0005). Some
constant associations between 0 type and core type were
apparent: all 26 06 isolates were R 1, and all 3 015 isolates
were R3. In contrast, 075 isolates were found among both
the R 1 and the R2 core types. The proportion of the R 1
isolates that belonged to one of the common 0 types was
greater among the blood culture isolates (32/48, 67%) than
among the urine culture isolates (34/64, 53%). This differ-
ence is not statistically significant (P = .177), but the num-
ber of R 1 isolates not belonging to the common 0 types
could account for the greater proportion of R 1 isolates
among the isolates from urine.
Relationship between R type. serum resistance, and LPS
chemotype among blood culture isolates. Serum resistance,
which is a property of most invasive strains ofE. coli [6], was
determined for all the blood culture isolates; 21 (26%) of 79
were serum sensitive. There were serum-sensitive isolates of
all the core types, but serum sensitivity was slightly less com-
mon among the Rl isolates (9/48, 19%) than among the
other R types (10/31, 32%). This difference may have been
due to the association of R 1 core with K 1 and K5 capsule,
since all of the 11 Kl isolates and all but 1 of the 10 K5
isolates from blood cultures were serum resistant.
Seventy ofthe 79 blood culture isolates produced a typical
ladder pattern of LPS in silver stains of proteinase K digests
(data not shown). The other 9 showed only one or a few
fast-moving bands, one corresponding to the unsubstituted
core. Three isolates were R 1, 3 were R2, 2 were R3, and 1
was RNC.
Discussion
We have described a group ofMAbs that are selective for
the LPS core ofE. coli. Some of the MAbs also bind to Salmo-
nella and Shigella strains that share E. coli core structures.
The MAbs do not bind to a range of other gram-negative
bacilli, confirming that the binding observed was specific.
We have shown that the binding of these antibodies in
ELISA to bacterial cells heated at 100°C corresponds to
their binding to unsubstituted (and in some cases O-substi-
tuted) LPS core in immunoblots.
Unsubstituted LPS core is present in smooth bacterial cells
but may not be readily accessible to MAbs in standard labora-
tory cultures [18, 19]. Core epitopes are, however, much
more accessible on bacterial cells grown in serum or in a
magnesium-depleted medium, which is thought to mimic the
conditions in the infected host [20]. Core epitopes also be-
come more accessible in bacterial preparations heated at
100°C [21, 22]. The expression and accessibility ofcore epi-
topes and the possible existence of cross-reactive epitopes
have important implications for immunotherapy of gram-
negative sepsis [23].
We have examined the binding of selected MAbs to
heated bacterial cells in ELISA. We could recognize three
mutually exclusive groups among E. coli isolates and labeled
them R 1, R2, and R3 after the corresponding rough mu-
tants. A fourth group, which could not be assigned to a partic-
ular core type, was referred to as RNC and is probably of
heterogeneous core type. We included in the RNC group the
strain that reacted with the R l-specific antibody but not with
the cross-reactive MAb. If this strain had been of R 1 core
type, a reaction with the cross-reactive MAb would have
been expected.
We anticipate that each of the groups Rl , R2, and R3
defined with MAbs probably has the core structure of the
named rough strain, though this has not been confirmed by
chemical analysis. The presence ofC21 sensitivity (a marker
for R 1 rough mutants) among the wild-type isolates ofMAb-
defined R 1 rather than R2 or R3 core type supports our view
that the MAb-defined core types are the same as the refer-
ence rough strains. Two RNC isolates were also C21 sensi-
tive, but the specificity of these phages for particular core
types is not based on an independent knowledge of their
receptor sites, and it is not known how they might react with
as-yet-unidentified core types of E. coli. Phage typing is of
little value in determining the core type ofwild-type isolates
since most are resistant to all of the phages used.
No isolates ofR4 or Kl2 core type were positively identi-
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fied. This may be explained by the lack of suitable specific
MAbs. We did have MAbs reactive with K12, but these also
reacted with R2 and did not bind to a clearly defined group
of wild-type isolates other than those that reacted with the
R2-specific MAbs. The RNC group may include isolates
with R4 or K 12 core but probably also contains one or more
as-yet-unidentified core types.
Comparison of the structural formulas [15] with the speci-
ficities of our MAbs could suggest binding of the MAbs to
particular sugar residues. Rl and R3 each have a unique
terminal branching hexosyl unit ({31-3-linked glucose and
a 1-3-linked N-acetylglucosamine, respectively) that may be
the epitope for the R 1and R3 antibodies. R2 and Salmonella
core share a terminal a 1-2-linked N-acetylglucosamine,
while R2 and K 12 have in common the next three sugar
residues. These may therefore be the epitopes for the MAbs
that bound to these combinations of strains. A unique bind-
ing site for the R2-specific antibody is not obvious from the
structural formulas. From the calculated three-dimensional
structure of the different core types [24], however, it appears
that the branch-terminating a 1-6 galactose present in R2,
Salmonel/a core, and K 12 may be in a different orientation
in R2 and may therefore be the R2-specific epitope. It is of
note that while most of the core-specific MAbs reacted in
immunoblot only with unsubstituted core, the R2-specific
MAb also reacted with a-substituted core, giving a ladder
pattern in immunoblots. This implies that the R2-specific
epitope is the only one not altered or masked by the attach-
ment of the a polysaccharide. Further study of the binding
site ofthese antibodies may therefore be useful in elucidating
the three-dimensional structure of LPS core and in attempts
to define the attachment site of the 0 polysaccharide.
The binding of the cross-reactive MAb SZ 27 150.3 to
almost all of the E. coli isolates and to the Salmonella and
Shigella strains, together with the pattern of binding of the
core-specific MAbs, supports the view that these organisms
share closely related LPS cores. The lack ofbinding ofany of
the antibodies to other genera suggests that these core struc-
tures are not distributed more widely. The structure of LPS
core has not been determined for all the other genera, but it
has been shown that the LPS cores of Citrobacter [25, 26]
Proteus [27], and Pseudomonas [28] species are different
from that of E. coli.
A MAb designated T6, which recognized the R2 core ofE.
coli and the core ofSalmonella species, did not react with 25
clinical isolates ofE. coli in Hong Kong [29], suggesting that
the R2 core type was rare. We have found, however, that R2
accounted for 8% of our collection of E. coli isolates. This
suggests that attempts to use MAb T6 in a capture ELISA
[22] to detect Salmonella organisms in clinical samples may
yield a significant number of false-positives because of the
presence of E. coli of R2 core type.
The tendencyfor certain apparently distinct properties of
E. coli to occur together [5] seems to apply to the relationship
between core types and 0 and K types. It may be that. there
are chemical or structural factors limiting the ability ofE. coli
to express certain combinations of a and core types (e.g.,
a 15 and R 1) or it may be that some such combinations have
a selective advantage in the host. The finding that there was
greater proportion of R I core type among the urine isolates
and in particular that there was a greater proportion of R 1
isolates not belonging to one of the common 0 types may
indicate some relationship between R 1 core type and un-
usual a types and pathogenicity in the urinary tract. Further
studies are needed before firm conclusions can be drawn on
this point.
Core typing with MAbs may be a useful addition to
current typing methods for E. coli. The number of possible
types is small, and the core type does not usually discrimi-
nate among strains of a given a and K type, but core typing
may be useful in recognizing relatedness between groups of
E. coli. We hope to use these antibodies to investigate the
LPS core type ofa wider range ofShigella and E. coli isolates
from a variety of sources.
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